Key Points Annovis received a U.S. patent covering buntanetap Form B, the crystalline form used in its ongoing Alzheimer’s and Parkinson’s studies. The patent covers…
November 13, 2026
October 14, 2026
Arrowhead’s Under-the-Skin Tau Data Puts Brain Delivery in Focus for Alzheimer’s Stocks
Arrowhead cut spinal fluid tau by a mean of 73% without a spinal injection. Denali, Voyager and Annovis are testing other routes to lower tau….